The Department of Health has strongly asked to avoid self-medication, as some medicines that circulate in networks are not only ineffective but can also affect the heart.
Read for 3 min
The Ministry of Health of the Government of Mexico indicated which drugs are used in the serious treatment of COVID-19 in Mexico and recommended not to use them when you are out of the hospital.
During the conference on the situation of the SARSCov2 pandemic in the Mexican Republic on July 15, the agency listed the drugs that are not recommended because they not only have no proven efficacy in the treatment of COVID-19, but also serious damage can cause organs such as the heart, kidneys and liver.
“The use of non-efficacy drugs outside of clinical trials is highly questionable and should be reported immediately to the health agency for use outside of the information to be prescribed,” said Simon Kawa Karasik, director general for coordination at the National Institutes of Health.
Alethse De la Torre Rosas, director general of the National Center for Prevention and Control of HIV and AIDS (Censida), asked the population with mild symptoms of COVID-19 to avoid self-medication.
Medicines that can be used THEN AND ONLY IF are used in controlled clinical trials in Patient taken to the hospital with COVID-19 under certain conditions and in very strict measures are:
- Baricitinib (combined with Remdesivir)
- Chloroquine / hydroxychloroquine
- Lopinavir / ritonavir
- Recovery plasma
“It has to be made very clear that the recommended medications only apply to patients who are hospitalized under very specific conditions with very clear management guidelines,” said the coordinator of the National Institutes of Health.
Medications NOT recommended
Medications that have no proven efficacy against COVID-19 and may have side effects are:
- Chlorine dioxide
- Transfer factor
- Intravenous immunoglobin and interferons
- Citrus nanomolecules
“We have drugs that have very clear indications for other pathologies and that are prescribed as a recommendation for patients with COVID-19 and that are completely out of the norm. They will be of no benefit to the patients,” emphasized Simon Kawa Karasik. .
As of July 15, Mexico reported 317,635 confirmed cases and 36,906 deaths from COVID-19.